ARTICLE | Company News
Altus Biologics Inc. other research news
June 17, 1996 7:00 AM UTC
Altus, a subsidiary of Vertex Pharmaceuticals Inc. (VRTX, Cambridge, Mass.), received a two-year, $750,000 NIH grant to develop CLEC (cross-linked enzyme crystal) technology for use in the manufactur...